{"analyses":[{"ciLowerLimit":"-11.50","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"23.00","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.8992","paramType":"Mean Difference (Net)","paramValue":"5.00","statisticalMethod":"ANCOVA"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-21.75","upperLimit":"59.37","value":"19.25"},{"groupId":"OG001","lowerLimit":"-24.99","upperLimit":"47.24","value":"8.00"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"63"}],"units":"Participants"}],"description":"Change in 6 Minute Walk Test (6MWT) Distance (meters)","dispersionType":"Inter-Quartile Range","groups":[{"description":"NEOD001, 24 mg/kg IV every 4 weeks for 12 months","id":"OG000","title":"NEOD001 24 mg/kg"},{"description":"Placebo, 0.9% Saline IV every 4 weeks for 12 months","id":"OG001","title":"Placebo"}],"paramType":"MEDIAN","populationDescription":"ITT Population","reportingStatus":"POSTED","timeFrame":"Baseline to 12 months of treatment","title":"6MWT Distance","type":"SECONDARY","unitOfMeasure":"meters"}